The investment seeks long-term capital appreciation... Show more
The AdvisorShares Pure Cannabis ETF (YOLO) is an actively managed exchange-traded fund (ETF) seeking long-term capital appreciation. It invests at least 80% of its net assets in securities of companies deriving at least 50% of net revenue from the marijuana and hemp business, and in derivatives with similar economic characteristics. The fund is classified as non-diversified and carries a net expense ratio of 0.51%.
YOLO holds roughly 20 to 23 securities, with a heavy concentration in its largest names. The AdvisorShares Pure US Cannabis ETF (MSOS) is the single largest holding at more than 20% of assets, followed by U.S. multi-state operators such as Trulieve Cannabis (TRLV) and Curaleaf Holdings, and Canadian operators including Village Farms International (VFF) and High Tide. By sector, healthcare exposure dominates at close to 60%, with consumer staples/defensive names representing most of the remainder. This concentrated, mostly small- and mid-cap portfolio explains the fund's outsized sensitivity to sector-specific news flow.
Over the trailing 30 days, YOLO fell approximately 23%, moving from about $3.36 per share in late September to roughly $2.59. The decline was not a steady grind lower; instead, the fund spiked sharply in late September before giving back those gains over the following weeks. This pattern reflects a headline-driven surge followed by fading momentum rather than a gradual, fundamentals-led selloff.
The three-month picture looks materially different. Measured against a level near $2.63 roughly one quarter earlier, YOLO is down only about 1.5%, effectively range-bound over the period. The contrast between the two time frames highlights how much of the recent 30-day move was a reversal of a brief rally rather than the start of a new trend.
The late-September spike was driven almost entirely by regulatory optimism. A federal appeals court cleared a key legal obstacle to the administration's effort to reschedule medical cannabis from Schedule I to Schedule III, reinforcing expectations that licensed medical operators would gain relief from Section 280E, which previously barred them from deducting ordinary business expenses. That ruling lifted the largest U.S. plant-touching names, which carry meaningful weight inside YOLO through both direct holdings and its MSOS position.
However, the rally quickly faded. Cannabis equities tend to run ahead of policy implementation and then consolidate as investors wait for tangible follow-through in earnings and cash flow. Trulieve (TRLV), the first U.S. plant-touching operator to list on a major U.S. exchange, and Curaleaf remain volatile as the market digests quarterly results, retail expansion, and index-inclusion dynamics. As the initial burst of enthusiasm cooled, YOLO drifted back toward the levels that prevailed before the catalyst, erasing most of the 30-day period's earlier gains.
Over the full quarter, YOLO's performance was shaped by the same structural themes but produced a net result near flat. The April 2026 rescheduling of state-licensed medical cannabis to Schedule III set the foundation for improved sentiment, enabling Trulieve's historic NYSE listing and prompting operators such as Curaleaf to pursue exchange uplistings and reverse splits. Index inclusion for several operators has begun to draw a more institutional shareholder base into a sector long dominated by retail and over-the-counter trading.
These structural improvements supported the sector, but they were offset by persistent volatility, uneven quarterly results, and the absence of federal banking reform. The quarter's net move of roughly -1.5% reflects a balance between meaningful regulatory progress and the sector's still-uncertain fundamental trajectory.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, and AI-generated signals. By combining performance characteristics with customizable criteria, the platform surfaces candidates that match a specific investment approach far more efficiently than manual screening. For investors seeking to identify emerging opportunities across sectors and themes, the AI Screener offers a practical way to streamline research and monitor shifting market conditions.
The outlook for YOLO remains tied to the pace of U.S. cannabis policy normalization. Investors should monitor the implementation timeline for Schedule III rescheduling, the scope of any Section 280E relief, and whether the IRS and Treasury issue guidance that converts tax benefits into measurable cash-flow improvements for operators. Progress on banking reform, including any safe-harbor legislation, would be a further catalyst for institutional capital flows into the sector.
Company-level execution also matters. Earnings, margin trends, retail expansion in key states such as Florida, and additional exchange uplistings or index inclusions will influence the fund's largest holdings. At the same time, concentration risk, thin liquidity, and the potential for policy setbacks argue for continued volatility. No single catalyst is likely to drive a sustained move; rather, a combination of regulatory clarity and improving operator fundamentals will determine whether the fund's recent round-trip gives way to a more durable trend.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
YOLO saw its Momentum Indicator move below the 0 level on November 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In 73 of the 76 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for YOLO turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 45 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for YOLO moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YOLO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
YOLO broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for YOLO entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where YOLO's RSI Oscillator exited the oversold zone, 34 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +14.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where YOLO advanced for three days, in 240 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows